Chemistry & biodiversity · 2025
Quantum Chemical and Metabolomic Characterization of Inhibitory Activity of Procyanidins and Flavonol Glucosides From Graptopetalum paraguayense E. Walther Against Nonstructural Proteins of SARS-CoV-2.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stoyanova Nina, Rangelov Miroslav, Todorova Nadezhda, Dincheva Ivayla, Badjakov Ilian, Enchev Venelin, Markova Nadezhda
Аннотация
This study explores the antiviral potential of Graptopetalum paraguayense against SARS-CoV-2 nonstructural proteins (NSPs). G. paraguayense, a plant known for its health benefits, has previously shown strong antiviral activity against HSV-1, and although the two viruses have different taxonomy, their effectiveness against the new coronavirus was also examined. LC-ESI-QTOF-MS/MS analysis identified 14 polyphenolic metabolites in G. paraguayense, including procyanidins and flavonol glucosides, compounds associated with anti-coronavirus properties. These compounds were tested using molecular docking and ONIOM(B3LYP/6-31+G(d,p):UFF) quantum chemical calculations to assess their binding affinity to eight SARS-CoV-2 NSPs critical for viral replication and transcription. The results revealed that G. paraguayense compounds, such as procyanidin B2, kaempferol-3-O-glucoside, and epicatechin-3-O-galactoside, had strong binding affinities to NSP14, NSP5, and NSP15, respectively, suggesting their potential to inhibit viral replication. Compared to known NSP inhibitors from the RCSB Protein Data Bank, G. paraguayense-derived compounds demonstrated comparable or superior interaction energies in several cases. This investigation highlights G. paraguayense's therapeutic potential as a natural antiviral against SARS-CoV-2. The findings provide new insights into the role of plant-derived polyphenols in targeting viral proteins and contribute to further experimental and clinical studies to validate these compounds as candidates for anti-coronavirus therapies.